Benefits (Tables)

12 Months Ended

Jun. 29, 2019

Retirement Benefits [Abstract]

Schedule of Net Funded Status [Table Text Block]

U.S. Employees Postretirement Medical Expense & Funded Status Reconciliation

The Company provides postretirement medical expenses to certain former employees of Dallas Semiconductor and to certain Maxim Integrated executives. The Company adopted the postretirement medical plan as a result of the Company's acquisition of Dallas Semiconductor in 2001. A reconciliation of the funded status of these postretirement benefits, is as follows:

	June 29, 2019			Estimated Fiscal Year 2020 Expense		June 30, 2018			Fiscal Year 2019 Expense
	(in thousands, except percentages)
Accumulated postretirement benefit obligation (APBO):
Retirees and beneficiaries	$	(18,241	)			$	(18,023	)
Active participants	(1,437		)			(1,367		)
Funded status	$	(19,678	)			$	(19,390	)
Actuarial gain (loss)	$	118				$	1,279
Prior service cost	—					—
Amounts recognized in accumulated other comprehensive income:
Net actuarial loss	$	1,172				$	1,054
Prior service cost	606					962
Total	$	1,778				$	2,016
Net periodic postretirement benefit cost:
Interest cost				$	695				$	741
Amortization:
Prior service cost				356					356
Total net periodic postretirement benefit cost				$	1,051				$	1,097
Employer contributions				$	747				$	571
Economic assumptions:
Discount rate	3.6%					3.9%
Medical trend	7.25% - 5.0%					7.5%-5.0%

Schedule of Expected Benefit Payments [Table Text Block]

The following benefit payments are expected to be paid:

	Non-Pension Benefits
Fiscal Year	(in thousands)
2020	$	747
2021	819
2022	877
2023	893
2024	948
Thereafter	15,394
Total	$	19,678